Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study

Who May Qualify: 1. \- Both genders aged 15-39 years 2. \- Patients who have CIPN associated with at least moderate symptoms of pain (≥4 on a 0-10 scale) or neuropathy. 3. \- Patients have had cancer and are not being actively treated, 4. \- Patients who speaks English and able to complete questionnaires by themselves or with help from parents and/or nurses. Written willing to sign a consent form will be obtained from adults (aged 18-39 years) or from parents/guardians of adolescents (aged 15-17 years) and assent will be obtained from adolescents (aged 15-17 years) under an Institutional Review Board (IRB)-approved protocol. Who Should NOT Join This Trial: 1. \- Inability to walk or stand without assistance (need for ambulatory-assist devices) 2. \- Bone and/or cancer that has spread to the brain that affect gait, walking and balance 3. \- History of other known or unknown causes of acute or chronic neuropathic and/or no neuropathic pain conditions. 4. \- Implanted intrathecal drug-delivery system or a spinal cord and/or peripheral nerve stimulator; a) a metal implant such as a cardiac pacemaker, automatic defibrillator, aneurysm clips, vena cava clips, or skull plate. 5. \- History of epilepsy. 6. \- Skin damage at the site of electrode placement; and i) prior ST treatment; j) Patients on pain medications for other than CIPN. Always talk to your doctor about whether this trial is right for you.